Capecitabine

본문 바로가기


Home > Product > Capecitabine
Selling leads
Capecitabine
Posting date : Aug 29, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

Capecitabine is an antimetabolic fluoropyrimidine deoxyribonucleoside carbamate drug that can be converted into 5-FU in the body. It was developed by Roche and is marketed as Xeloda. It can inhibit cell division and interfere with the synthesis of RNA and protein. It is indicated for further treatment of advanced primary or metastatic breast cancer that is unresponsive to paclitaxel and chemotherapy regimens including anthracycline antibiotics. It is mainly used for the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top